Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 13, Issue 8, 2011, Pages 837-842

  Araszkiewicz, Aleksandra ^a   Naskret, Dariusz ^a   Niedzwiecki, Pawel ^a   Samborski, Pawel ^a   Wierusz Wysocka, Bogna ^a   Zozulinska Ziolkiewicz, Dorota ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; ARTICLE; AUTOFLUORESCENCE; BIOACCUMULATION; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NON INVASIVE PROCEDURE; PATIENT ASSESSMENT; PRIORITY JOURNAL; SKIN EXAMINATION; TISSUE DISTRIBUTION;

ADULT; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; SKIN; YOUNG ADULT;

EID: 79960401702     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0043     Document Type: Article

References (19)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin- dependent diabetes mellitus. The Diabetes Control and Complications Research Group. N Engl J Med 1993;329:977-986.
2. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999;22:99-111.
3. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-1625. (Pubitemid 40770750)
4. Brownlee M: Negative consequences of glycation. Metabolism 2000;49:9-13. (Pubitemid 30091786)
5. Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR: Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med 1986;314:403-408. (Pubitemid 16161885)
6. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, Smit AJ: Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 2006;29:2654-2659. (Pubitemid 44912194)
7. Dorrian CA, Cathcart S, Clausen J, Shapiro D, Dominiczak MH: Factors in human serum interfere with the measurement of advanced glycation endproducts. Cell Mol Biol 1998;44:1069-1079.
8. Meerwaldt R, Links T, Zeebregts C, Tio R, Hillebrands JL, Smit A: The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovasc Diabetol 2008;7:29.
9. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004;47:1324-1330. (Pubitemid 39093330)
10. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT; Global Diabetic Retinopathy Project Group: Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-1682. (Pubitemid 37025422)
11. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007;49(2 Suppl 2):S12-S154.
12. Meerwaldt R, Links TP, Graaff R, Hoogenberg K, Lefrandt JD, Baynes JW, Gans RO, Smit AJ: Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia 2005;48:1637-1644. (Pubitemid 41175518)
13. Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO, Smit AJ: Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007;30:107-112. (Pubitemid 46052507)
14. Chabroux S, Canoui-Poitrine F, Reffet S, Mills-Joncour G, Morelon E, Colin C, Thivolet C: Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy. Diabetes Metab 2010;36:152-157.
15. Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J, Sivity W, Monnier VM: Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications participants with type 1 diabetes. Diabetes 2005;54:3103-3111. (Pubitemid 43334362)
16. Yamagishi S,Ueda S,Matsui T,Nakamura K,Okuda S: Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Curr Pharm Des 2008;14:962-968. (Pubitemid 351753283)
17. Goh SY, Cooper ME: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008;93:1143-1152. (Pubitemid 351519698)
18. Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, Smit AJ, Gans RO, Bilo HJ: Skin autofluorescence. A tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care 2008;31: 517-521.
19. Monami M, Lamanna C, Gori F, Bartalucci F, Marchionni N, Mannucci E: Skin autofluorescence in type 2 diabetes: beyond blood glucose. Diabetes Res Clin Pract 2008;79:56-60.